Federal appeals court hears CRISPR patent dispute
By Jon Cohen,
Science
| 04. 30. 2018
Here’s a double-negative brain twister with potentially huge financial ramifications and a Nobel Prize resting on the answer: For an invention to be “nonobvious”—and therefore patentable in the United States—should there be no guarantee of success when researchers embark on experiments that lead to the invention?
That mind-bending question was the centerpiece of a case heard today by the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., over the lucrative patent portfolio surrounding the revolutionary genome editor commonly known as CRISPR. This 2-year-old intellectual property battle pits lawyers from the University of California (UC) against litigators from the Broad Institute in Cambridge, Massachusetts. Both teams represent groups of researchers from several institutions who claim to have made the key discoveries that allow CRISPR, which bacteria naturally use as an immune mechanism, to make precise cuts in the genomes of mammals—technology that ultimately may pave the way for new medical treatments. The invention has spawned several companies, and many expect it will lead to Nobel Prizes for the key scientists.
In April 2014, Broad received the first of...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Kaitlin Sullivan, NBC News | 10.15.2025
Two months after she was born, Eliana Nachem got a cough that wouldn’t go away. Three weeks later, she also started having runny stool, prompting a visit to her pediatrician.
Eliana didn’t have allergies or a gastrointestinal condition; instead, tests...